期刊文献+

血小板膜糖蛋白及其Ⅰ bα kozak位点基因多态性与缺血性脑血管病关系的研究 被引量:3

Study on association between platelet membrane glycoprotein and itsⅠbαkozak site gene polymorphism with ischemic cerebrovascular disease
下载PDF
导出
摘要 目的探讨血小板膜糖蛋白(GP)Ⅰbα基因kozak位点基因多态性及GPⅠb/ⅠⅩ/Ⅴ复合物表达量在缺血性脑血管病患者的变化特点,明确二者在缺血性脑血管病发病机制中的作用。方法采用ELISA法测定GPⅠb/ⅠⅩ/Ⅴ的表达量。采用实时荧光聚合酶链反应(PCR)技术确定缺血性脑血管病组和对照组GPⅠbαkozak位点基因多态性。采用二磷酸腺苷诱导比浊法测定血小板聚集率。结果 (1)缺血性脑血管病组血清GPⅠb/ⅠⅩ/Ⅴ复合物的表达量与对照组比较,差异有统计学意义(P<0.05)。(2)缺血性脑血管病组和对照组比较,GPⅠbαkozak位点基因型分布和C等位基因频率比较,差异有统计学意义(P<0.05)。(3)缺血性脑血管病组和对照组在GPⅠbαkozak位点,C等位基因携带者血清GPⅠb/ⅠⅩ/Ⅴ复合物表达水平高于TT型,差异有统计学意义(P<0.05)。(4)血小板聚集率在缺血性脑血管病组明显高于对照组(P<0.01)。相关性分析结果显示,缺血性脑血管病组血小板聚集率与GPⅠb/ⅠⅩ/Ⅴ复合物表达水平呈正相关(r=0.684)。结论 (1)缺血性脑血管病患者血清高表达GPⅠb/ⅠⅩ/Ⅴ复合物。(2)缺血性脑血管病发病的易感基因是GPⅠbαkozak位点C等位基因。(3)血小板聚集率增高与缺血性脑血管病的发病有很大相关性。(4)GPⅠbαkozak位点基因突变作为遗传因素引起血清GPⅠb/ⅠⅩ/Ⅴ复合物表达增高。(5)GPⅠb/ⅠⅩ/Ⅴ复合物高表达导致了血小板聚集率的增高。 Objective To investigate the gene polymorphism of platelet membrane glycoprotein Ⅰbαgene kozak site and the change characteristics of expression amount of GPⅠb/ⅠⅩ/Ⅴcomplex in the patients with ischemic cerebrovascular disease and to determine their role in the pathogensis of ischemic cerebrovascular disease.Methods The enzyme-linked immunosorbent assay(ELISA)was adopted to measure the GPⅠb/ⅠⅩ/Ⅴ complex expression amount.The Taqman real-time PCR technology was used to determine the gene polymorphism of GPⅠbαkozak site in the ischemic cerebrovascular disease group and the healthy control group.The platelet agglutination rate was detected by using the ADP inducing turbidimetry.Results(1)The expression amount of serum GPⅠb/ⅠⅩ/Ⅴ complex had statistical difference between the ischemic cerebrovascular disease group and the control group(P〈0.05).(2)The distribution of GPⅠbαkozak site genotypes and the C allele frequency had statistical difference between the ischemic cerebrovascular disease group and the control group(P〈0.05).(3)The expression level of serum GPⅠb/ⅠⅩ/Ⅴ complex at the GPⅠbαkozak site in the carriers with C allele in the ischemic cerebrovascular disease group and the control group was higher than that with TT genotype,the difference was statistically significant(P〈0.05).(4)The ischemic cerebrovascular disease group had significantly higher platelet agglutination rate than the control group(P〈0.01).The correlation analysis results showed that the platelet agglutination rate in the ischemic cerebrovascular disease group was positively correlated with GPⅠb/Ⅰ Ⅹ/Ⅴ complex expression level(r=0.684).Conclusion(1)The ischemic cerebrovascular disease patients have a high expression of GPⅠb/Ⅰ Ⅹ/Ⅴcomplex.(2)Ischemic cerebrovascular disease has a susceptibility gene C allele at GPⅠbαkozak site.(3)The increase of platelet agglutination rate is highly correlated with ischemic cerebrovascular disease occurrence.(4)GPⅠbαkozak site gene mutation serves as a genetic factor causing elevating of the GPⅠb/ⅠⅩ/Ⅴcomplex level.(5)The high expression of GPⅠb/ⅠⅩ/Ⅴ complex results in the increase of platelet agglutination rate.
出处 《检验医学与临床》 CAS 2016年第4期440-442,445,共4页 Laboratory Medicine and Clinic
基金 辽宁省自然科学基金项目(201102240)
关键词 血小板膜糖蛋白 基因多态性 缺血性脑血管病 脑血管病 glycoprotein polymorphism ischemic stroke cerebral vascular diseases
  • 相关文献

参考文献11

  • 1Donald L J, Adams R J, Brown TM, et al. Heart disease and stroke statistics 2010 update:a report /rom the American Heart Associationf-J ]. Circulation, 2010,121 ( 7 ) : 210-215.
  • 2Esen FI, Hancer VS, Ktictikkaya RD, et al. Glycoprotein Ib-alpha Kozak polymorphism in ischemic stroke[J]. Neu rol Res,2012,34(1) =68-71.
  • 3Simsek S, Faber NM, Bleeker PM, et al. Determination of human platelet antigen frequencies in the Dutch popula tion by immunophenotyping and DNA analysis[J]. Blood. 1993,81 (3) : 835-840.
  • 4Meyer SF,Schwarz T, Schatzberg D,et al. Platelet glyco pro'rein Ib-c is an important mediator of ischemic stroke in mice[J]. Exp Translat Stroke Med, 2011,3 (8) : 9-11.
  • 5Afshar-Kharghan V, Li CQ, Khoshnevis-Asl M, et al. Kozak sequence polymorphism of the glycoprotein (GP) Ibalpha gene is a major determinant of the plasma mem- brane levels of the platelet GP I b- I X-V eomplex[J]. Blood, 1999,94(1) :186 191.
  • 6Hsieh K, Funk M, Schillinger M, et al. Vienna Stroke Registry. Impact of the platelet glycoprotein I b alpha Kozak polymorphism on the risk of ischemic cerebrovas cular events:a case-control study[J]. Blood Coagul Fibri- nolysis,2004,15(6) :469-473.
  • 7Baker RI, Eikelboom J, Lofthouse E, et al. Platelet glyco protein Ibalpha Kozak polymorphism is associated with an increased risk of ischemie strokef-J]. Blood, 2001,98 ( 1 ) : 36-40.
  • 8Pina-Cabral I.B, Carvalhaisa V, Mesquitaa P,. Allelic and gen- otypie frequencies of platelet glyeoprotein polymor- phisms in a Portuguese population[J]. Rev Port Cardiol, 2013,32(2) : 111-115.
  • 9Hancer VS, Diz-Kiictikkaya R, Nalcaci M. Turkish popu lation dataon the factor XIII Va134Leu,glycoprotein Ib alpha Kozak and p selectin glycoprotein ligand ] loci[J]. Cell Biochem Funct, 2005,23 (1) : 55-58.
  • 10张爱琴,郑敏,郝跃伟,赵婷婷,刘雪平.脑梗死患者血小板膜糖蛋白Ⅰ bα基因HPA-2、Kozak位点多态性分析[J].山东医药,2010,50(38):23-24. 被引量:2

二级参考文献6

共引文献2

同被引文献14

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部